The development and validation of a simulation tool for health policy decision making

Journal of Biomedical Informatics

Volumn 43, Issue 4, 2010, Pages 602-607

  Panchanathan, Sarada S ^a   Petitti, Diana B ^b   Fridsma, Douglas B ^b  

^a Maricopa Integrated Health System   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Abscess; Methicillin resistant; MRSA; Simulation; Soft tissue infection; Staphylococcus

Indexed keywords

HEALTH POLICY; INFECTIOUS DISEASE; LOCAL DATA; MAKING DECISION; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POLICY MAKERS; RIGOROUS APPROACH; SIMULATION DEVELOPMENT; SIMULATION RESULT; SIMULATION TOOL; SOFT TISSUE INFECTIONS;

DECISION MAKING; SENSITIVITY ANALYSIS; TISSUE;

COMPUTER SIMULATION;

ARTICLE; CLINICAL DECISION MAKING; CLINICAL EVALUATION; COMPUTER MODEL; COMPUTER SIMULATION; HEALTH CARE POLICY; INFECTION CONTROL; INFECTION RATE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; VALIDATION PROCESS; LEGISLATION AND JURISPRUDENCE; PATHOGENICITY; PENICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; VALIDATION STUDY;

ANTI-BACTERIAL AGENTS; COMPUTER SIMULATION; HEALTH POLICY; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

ANTIINFECTIVE AGENT;

EID: 77954145108     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2010.03.013     Document Type: Article

References (29)

1. Brewer T.F., Heymann S.J., Harris J.B. Tuberculosis control in Asia and the western Pacific: a role for computer modelling. Ann Acad Med Singapore 1997, 26(5):642-646.
2. Jacquez J.A., Koopman J.S., Simon C.P., Longini I.M. Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr 1994, 7(11):1169-1184.
3. Milne G.J., Kelso J.K., Kelly H.A., Huband S.T., McVernon J. A small community model for the transmission of infectious diseases: comparison of school closure as an intervention in individual-based models of an influenza pandemic. PLoS ONE 2008, 3(12):e4005.
4. D'Agata E.M., Webb G.F., Horn M.A., Moellering R.C., Ruan S. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 2009, 48(3):274-284.
5. Brockmann S.O., Schwehm M., Duerr H.P., et al. Modeling the effects of drug resistant influenza virus in a pandemic. Virol J 2008, 5:133.
6. Elveback L.R., Fox J.P., Ackerman E., Langworthy A., Boyd M., Gatewood L. An influenza simulation model for immunization studies. Am J Epidemiol 1976, 103(2):152-165.
7. Lee B.Y., Bedford V.L., Roberts M.S., Carley K.M. Virtual epidemic in a virtual city: simulating the spread of influenza in a US metropolitan area. Transl Res 2008, 151(6):275-287. 10.1016/j.trsl.2008.02.004.
8. Walensky R.P., Goldie S.J., Sax P.E., et al. Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy. J Acquir Immune Defic Syndr 2002, 31(1):27-37.
9. Arenas A.J., Gonzalez-Parra G., Morano J.A. Stochastic modeling of the transmission of respiratory syncytial virus (RSV) in the region of Valencia, Spain. BioSystems 2009, 96(3):206-212.
10. Grassly N.C., Fraser C. Mathematical models of infectious disease transmission. Nat Rev Microbiol 2008, 6(6):477-487.
11. Coburn B.J., Wagner B.G., Blower S. Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Med 2009, 7:30.
12. Eichner M., Schwehm M., Duerr H.P., Brockmann S.O. The influenza pandemic preparedness planning tool InfluSim. BMC Infect Dis 2007, 7:17.
13. Bhunu C.P., Garira W., Mukandavire Z. Modeling HIV/AIDS and tuberculosis coinfection. Bull Math Biol 2009, 71(7):1745-1780.
14. Musgrave J., Watmough J. Examination of a simple model of condom usage and individual withdrawal for the HIV epidemic. Math Biosci Eng 2009, 6(2):363-376.
15. Unal B., Capewell S., Critchley J.A. Coronary heart disease policy models: a systematic review. BMC Public Health 2006, 6:213.
16. Awad S.S., Elhabash S.I., Lee L., Farrow B., Berger D.H. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy. Am J Surg 2007, 194(5):606-610.
17. Frazee B.W., Lynn J., Charlebois E.D., Lambert L., Lowery D., Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005, 45(3):311-320.
18. Fridkin S.K., Hageman J.C., Morrison M., Sanza L.T., Como-Sabetti K., Jernigan J.A., et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352(14):1436-1444.
19. Fritz S.A., Garbutt J., Elward A., Shannon W., Storch G.A. Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus colonization in children seen in a practice-based research network. Pediatrics 2008, 121(6):1090-1098.
20. Haley C.C., Mittal D., Laviolette A., Jannapureddy S., Parvez N., Haley R.W. Methicillin-resistant Staphylococcus aureus infection or colonization present at hospital admission: multivariable risk factor screening to increase efficiency of surveillance culturing. J Clin Microbiol 2007, 45(9):3031-3038.
21. Marschall J., Muhlemann K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infect Control Hosp Epidemiol 2006, 27(11):1206-1212.
22. McBryde E.S., Bradley L.C., Whitby M., McElwain D.L. An investigation of contact transmission of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2004, 58(2):104-108.
23. Ho P.L., Cheung C., Mak G.C., Tse C.W., Ng T.K., Cheung C.H., et al. Molecular epidemiology and household transmission of community-associated methicillin-resistant Staphylococcus aureus in Hong Kong. Diagn Microbiol Infect Dis 2007, 57(2):145-151.
24. Creech C.B., Kernodle D.S., Alsentzer A., Wilson C., Edwards K.M. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 2005, 24(7):617-621.
25. Salgado C.D., Farr B.M., Calfee D.P. Community-acquired methcillin-resistant Staphylococcus aureus: a metaanalysis of prevalence and risk factors. Clin Infect Dis 2003, 36:131-139.
26. Ellis M.W., Griffith M.E., Dooley D.P., McLean J.C., Jorgensen J.H., Patterson J.E., et al. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother 2007, 51(10):3591-3598.
27. Gorwitz R.J., Kruszon-Moran D., McAllister S.K., McQuillan G., McDougal L.K., Fosheim G.E., et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008, 197(9):1226-1234.
28. Alfaro C., Mascher-Denen M., Fergie J., Purcell K. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in patients admitted to Driscoll Children's Hospital. Pediatr Infect Dis J 2006, 25(5):459-461.
29. Rim J.Y., Bacon A.E. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus colonization in a random sample of healthy individuals. Infect Control Hosp Epidemiol 2007, 28(9):1044-1046.